AIMD vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 17, 2026

AIMD

33.2
AI Score
VS
MLAB Wins

MLAB

38.6
AI Score

Investment Advisor Scores

AIMD

33score
Recommendation
AVOID NEW MONEY

MLAB

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric AIMD MLAB Winner
Forward P/E 13.9082 34.4828 AIMD
PEG Ratio 0.9278 0 Tie
Revenue Growth -96.7% 1.0% MLAB
Earnings Growth 0.0% -42.4% AIMD
Tradestie Score 33.2/100 38.6/100 MLAB
Profit Margin 0.0% 1.9% MLAB
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

AIMD 1M: -41.9% · 3M: -37.1% MLAB 1M: -6.4% · 3M: +31.6%

Current Technical Phase

AIMD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.4%), weak momentum, RSI 19

RSI (14): 18.9 · Price: $0.84

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.4% over 20 days), RSI 52

RSI (14): 51.6 · Price: $128.66

Fundamentals Snapshot

Metric AIMD MLAB
Market Cap — —
Forward P/E 13.9 23.9
Trailing P/E — 151.9
Revenue (TTM) — —
Revenue Growth -1.0% 0.0%
Gross Margin 0.8% 0.6%
Operating Margin -28941.4% 0.1%
EPS -2.54 0.85
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, MLAB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.